You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HL-085

Showing 1 - 25 of 224
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-small-cell Lung Cancer Trial (HL-085+Vemurafenib)

Not yet recruiting
  • Non-small-cell Lung Cancer
  • (no location specified)
Jun 8, 2023

Melanoma Trial in Beijing (HL-085, Vemurafenib)

Recruiting
  • Melanoma
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Apr 10, 2022

Neurofibromatosis 1, Plexiform Neurofibromas Trial in Shanghai (HL-085)

Recruiting
  • Neurofibromatosis 1
  • Plexiform Neurofibromas
  • HL-085
  • Shanghai, Shanghai, China
    Shanghai Ninth People's Hospital, Shanghai JiaoTong University S
Apr 10, 2022

Melanoma Trial in Beijing (HL-085)

Recruiting
  • Melanoma
  • HL-085
  • Beijing, Beijing, China
  • +1 more
Jan 19, 2022

CRC Trial in Beijing (HL-085, Vemurafenib)

Not yet recruiting
  • CRC
  • Beijing, Beijing, China
    Beijing Oncology Hospital
Feb 6, 2022

Nsclc Trial in Beijing (HL-085, Docetaxel)

Terminated
  • Nsclc
  • Beijing, China
    Cancer Hospital Chinese Academy of Medical Science
Nov 29, 2021

Melanoma Trial in Beijing, Shanghai (HL-085)

Recruiting
  • Melanoma
  • HL-085
  • Beijing, Beijing, China
  • +1 more
Dec 16, 2021

Solid Tumor Trial in Beijing, Zhengzhou, Hangzhou (HL-085, Vemurafenib)

Recruiting
  • Solid Tumor
  • Beijing, Beijing, China
  • +3 more
Jan 20, 2022

Solid Tumor, Adult Trial in United States (HL-085)

Recruiting
  • Solid Tumor, Adult
  • HL-085
  • San Marcos, California
  • +4 more
Mar 17, 2021

Solid Tumor, Adult Trial in Austin, San Antonio (HL-085)

Terminated
  • Solid Tumor, Adult
  • HL-085
  • Austin, Texas
  • +1 more
Nov 16, 2020

Colorectal Cancer Metastatic Trial (Tunlametinib plus Vemurafenib, Doublets Chemotherapy ± Bevacizumab or Doublets Chemotherapy

Not yet recruiting
  • Colorectal Cancer Metastatic
  • Tunlametinib plus Vemurafenib
  • Doublets Chemotherapy ± Bevacizumab or Doublets Chemotherapy ± Cetuximab
  • (no location specified)
Aug 15, 2023

Melanoma Trial in Beijing (tunlametinib, paclitaxel +carboplatin, or temozolomide +cisplatin, or dacarbazine +cisplatin)

Not yet recruiting
  • Melanoma
  • tunlametinib
  • paclitaxel +carboplatin, or temozolomide +cisplatin, or dacarbazine +cisplatin
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Aug 15, 2023

Moderate to Severe Plaque Psoriasis Trial in Saint Petersburg (BCD-085 Q2W, BCD-085 Q4W, Placebo)

Completed
Has Results
  • Moderate to Severe Plaque Psoriasis
  • BCD-085 Q2W
  • +2 more
  • Saint Petersburg, Strelna, Russian Federation
    BIOCAD
May 11, 2022

HIV Infection, HIV-associated Hodgkin Lymphoma, Stage III Adult Hodgkin Lymphoma Trial in France (brentuximab vedotin,

Active, not recruiting
  • HIV Infection
  • +3 more
  • brentuximab vedotin
  • +3 more
  • Clamart, France
  • +5 more
Aug 11, 2022

AIDS-Related Hodgkin Lymphoma, Ann Arbor Stage II Hodgkin Lymphoma, Ann Arbor Stage IIA Hodgkin Lymphoma Trial in France, United

Active, not recruiting
  • AIDS-Related Hodgkin Lymphoma
  • +11 more
  • Brentuximab Vedotin
  • +4 more
  • La Jolla, California
  • +27 more
Jul 27, 2022

Healthy Subjects, Sports Level 1 Trial in Denpasar (Low-load Blood Flow Restriction training, Sham Low-load Blood Flow

Not yet recruiting
  • Healthy Subjects
  • Sports Level 1
  • Low-load Blood Flow Restriction training
  • +2 more
  • Denpasar, Bali, Indonesia
    Physical therapy laboratory, College of Medicine, Universitas Ud
Jul 10, 2023

Health Knowledge, Attitudes, Practice, Health Behavior, Health Literacy Trial in Holbaek (An integrated health literacy

Recruiting
  • Health Knowledge, Attitudes, Practice
  • +3 more
  • An integrated health literacy intervention
  • Holbaek, Region Sjælland, Denmark
    Department of Occupational and Social Medicine, Holbaek Hospital
Aug 28, 2023

Ankylosing Spondylitis Trial (BCD-085, Placebo)

Completed
  • Ankylosing Spondylitis
  • (no location specified)
Oct 25, 2021

ALL, Hodgkin Lymphoma, Cancer Trial in Memphis (Transcranial photobiomodulation (tPBM) - Mobile System)

Not yet recruiting
  • ALL
  • +3 more
  • Transcranial photobiomodulation (tPBM) - Mobile System
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Dec 6, 2022

Health Literacy in the Municipality of Leiria

Not yet recruiting
  • Health Literacy
    • (no location specified)
    Sep 26, 2022

    COPD Trial in Saint Louis (Get Palliative Care: four educational learning module videos)

    Not yet recruiting
    • COPD
    • Get Palliative Care: four educational learning module videos
    • Saint Louis, Missouri
      Missouri Baptist Medical Center
    Oct 12, 2023

    Neuropathic Pain Trial (drug, behavioral, other)

    Not yet recruiting
    • Neuropathic Pain
    • Ketamine Hydrochloride
    • +2 more
    • (no location specified)
    Nov 28, 2022

    Nasopharyngeal Carriage of Children and Adolescents Based on

    Recruiting
    • Pneumonia
    • NP/OP swab
    • Baisha, Hainan, China
    • +4 more
    Jun 24, 2023

    Non-Hodgkin Lymphoma, Hodgkin Lymphoma Trial in Minneapolis (drug, procedure, biological, radiation)

    Recruiting
    • Non-Hodgkin Lymphoma
    • Hodgkin Lymphoma
    • Minneapolis, Minnesota
      Masonic Cancer Center, University of Minnesota
    Jan 25, 2023

    Aging Well Trial in Ann Arbor (Nurse-led health coaching)

    Not yet recruiting
    • Aging Well
    • Nurse-led health coaching
    • Ann Arbor, Michigan
      University of Michigan School of Nursing
    Jun 16, 2023